Article Dans Une Revue Microorganisms Année : 2021

Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins

Résumé

Bacteriocins produced by lactic acid bacteria (LAB-bacteriocins) may serve as alternatives for aging antibiotics. LAB-bacteriocins can be used alone, or in some cases as potentiating agents to treat bacterial infections. This approach could meet the different calls and politics, which aim to reduce the use of traditional antibiotics and develop novel therapeutic options. Considering the clinical applications of LAB-bacteriocins as a reasonable and desirable therapeutic approach, it is therefore important to assess the advances achieved in understanding their modes of action, and the resistance mechanisms developed by the producing bacteria to their own bacteriocins. Most LAB-bacteriocins act by disturbing the cytoplasmic membrane through forming pores, or by cell wall degradation. Nevertheless, some of these peptides still have unknown modes of action, especially those that are active against Gram-negative bacteria. Regarding immunity, most bacteriocin-producing strains have an immunity mechanism involving an immunity protein and a dedicated ABC transporter system. However, these immunity mechanisms vary from one bacteriocin to another.

Fichier principal
Vignette du fichier
microorganisms-09-02107.pdf (4.15 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04549722 , version 1 (17-04-2024)

Licence

Identifiants

Citer

Adrián Pérez-Ramos, Désiré Madi-Moussa, Françoise Coucheney, Djamel Drider. Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins. Microorganisms, 2021, 9 (10), pp.2107. ⟨10.3390/microorganisms9102107⟩. ⟨hal-04549722⟩
77 Consultations
214 Téléchargements

Altmetric

Partager

  • More